RVTY - Revvity, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $1.03
|
Rev Est: $704.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$115.14
DETAILS
HIGH:
$129.00
LOW:
$105.00
MEDIAN:
$118.00
CONSENSUS:
$115.14
UPSIDE:
17.95%
Market Cap:
11.33B
Volume:
705,521
Avg Volume:
1,555,205
52 Week Range:
81.36-120.39
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.09
Last Dividend:
$0.28
Exchange:
NYSE
Country:
US
Employees:
11,000
IPO Date:
1965-07-06
EPS (TTM):
2.08
P/E Ratio:
45.32
Revenue (TTM):
2.86B
Total Assets:
12.17B
Total Debt:
3.52B
Cash & Equiv:
919.87M
Rev Growth (5Y):
-0.2%
EPS Growth (5Y):
0.2%
FCF Growth (5Y):
10.3%
ROCE:
3.2%
Debt/Equity:
0.48
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-02 | $1.70 | $1.63 | +4.3% | $772.1M | $704.8M | +9.5% |
| 2025-10-27 | $1.18 | $1.14 | +3.5% | $698.9M | $699.4M | 0.0% |
| 2025-07-28 | $1.18 | $1.14 | +3.5% | $720.3M | $699.9M | +2.9% |
| 2025-04-28 | $1.01 | $0.96 | +5.2% | $664.8M | $710.8M | -6.5% |
| 2025-01-31 | $1.42 | $1.37 | +3.6% | $729.4M | $665.3M | +9.6% |
| 2024-11-04 | $1.28 | $1.13 | +13.3% | $684.0M | $679.7M | +0.6% |
| 2024-07-29 | $1.22 | $1.12 | +8.9% | $691.7M | $690.3M | +0.2% |
| 2024-04-29 | $0.98 | $0.94 | +3.9% | $649.9M | $647.2M | +0.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.86B | 2.76B | 2.75B | 3.31B | 3.83B | 3.78B | 2.88B | 2.78B | 2.26B | 2.12B | 2.10B | 2.24B |
| Net Income | 241.68M | 295.83M | (118.38M) | 569.18M | 943.16M | 728.10M | 227.56M | 238.79M | 113.02M | 233.68M | 212.45M | 158.04M |
| EPS | 2.08 | 2.41 | -0.95 | 4.51 | 8.12 | 6.53 | 2.05 | 2.16 | 1.03 | 2.13 | 1.89 | 1.40 |
| Total Assets | 12.17B | 12.39B | 13.56B | 14.13B | 15.00B | 7.96B | 6.54B | 5.98B | 6.09B | 4.28B | 4.17B | 4.13B |
| Total Debt | 3.52B | 3.33B | 4.07B | 4.60B | 5.16B | 2.22B | 2.26B | 1.89B | 2.01B | 1.05B | 1.01B | 1.05B |
| Cash & Equivalents | 919.87M | 1.16B | 913.16M | 454.36M | 603.32M | 402.04M | 191.88M | 163.11M | 202.13M | 359.26M | 237.93M | 174.82M |
| Operating Cash Flow | 581.78M | 628.30M | 91.27M | 679.81M | 1.41B | 892.18M | 363.47M | 311.04M | 288.45M | 350.62M | 287.10M | 281.60M |
| Free Cash Flow | 508.25M | 541.65M | 9.90M | 594.18M | 1.32B | 828.54M | 282.14M | 217.78M | 249.36M | 318.91M | 257.47M | 252.53M |
| FCF per Share | 4.49 | 4.41 | 0.08 | 4.71 | 11.40 | 7.43 | 2.55 | 1.97 | 2.27 | 2.91 | 2.29 | 2.24 |
| Book Value | 7.25B | 7.67B | 7.87B | 7.38B | 7.14B | 3.74B | 2.81B | 2.58B | 2.50B | 2.15B | 2.11B | 2.04B |
| Cash & ST Investments | 919.87M | 1.16B | 1.60B | 454.36M | 603.32M | 402.04M | 191.88M | 163.11M | 202.13M | 359.26M | 237.93M | 174.82M |
| ROC Equity | 0.03 | 0.04 | -0.02 | 0.08 | 0.13 | 0.19 | 0.08 | 0.09 | 0.05 | 0.11 | 0.10 | 0.08 |